PK Subtrial in Adolescent Patients With HAE Type I or II Participating in the KVD900-302 Trial
Public ClinicalTrials.gov record NCT05511922. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Pharmacokinetic Subtrial in Adolescent Patients With Hereditary Angioedema Type I or II Participating in the KVD900-302 Trial
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a multicenter pharmacokinetic (PK) subtrial to investigate the PK profile of KVD900 (sebetralstat) in adolescent patients 12 to 17 years of age with Hereditary Angioedema (HAE) type I or II.
Study identification
- NCT ID
- NCT05511922
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 11 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 24, 2022 (Actual)
- Primary completion
- May 27, 2026 (Actual)
- Completion
- May 27, 2026 (Actual)
- Last update posted
- Jun 8, 2026
2022 – 2026
United States locations
- U.S. sites
- 20
- U.S. states
- 16
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| KalVista Investigative Site | Scottsdale | Arizona | 85251 | — |
| KalVista Investigative Site | Little Rock | Arkansas | 72205 | — |
| KalVista Investigative Site | San Diego | California | 92122 | — |
| KalVista Investigative Site | San Diego | California | 92123 | — |
| KalVista Investigative Site | Santa Monica | California | 90404 | — |
| KalVista Investigative Site | Centennial | Colorado | 80112 | — |
| KalVista Investigative Site | Colorado Springs | Colorado | 80907 | — |
| KalVista Investigative Site | Evansville | Indiana | 47715 | — |
| KalVista Investigative Site | Overland Park | Kansas | 66211 | — |
| KalVista Investigative Site | Louisville | Kentucky | 40215 | — |
| KalVista Investigative Site | Chevy Chase | Maryland | 20815 | — |
| KalVista Investigative Site | Plymouth | Minnesota | 55446 | — |
| KalVista Investigative Site | St Louis | Missouri | 63141 | — |
| KalVista Investigative Site | Charlotte | North Carolina | 28277 | — |
| KalVista Investigative Site | Cincinnati | Ohio | 45236 | — |
| KalVista Investigative Site | Toledo | Ohio | 43617 | — |
| Kalvista Investigative Site | Hershey | Pennsylvania | 17033 | — |
| KalVista Investigative Site | Dallas | Texas | 75231 | — |
| KalVista Investigative Site | Layton | Utah | 84041 | — |
| KalVista Investigative Site | Spokane | Washington | 99204 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 41 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05511922, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 8, 2026 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05511922 live on ClinicalTrials.gov.